SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Operating Margin Over TimeStrong
Percentile Rank83
Studio
Year-over-Year Change

Operating income as a percentage of revenue

Latest
0.00%
↑ 100% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive growthStrong
Average
-757.60%
Historical baseline
PeriodValueYoY Change
20250.00%+100.0%
2024-3244.87%-90.8%
2023-1700.54%-1305.7%
2022-120.98%-449.9%
2021-22.00%-159.1%
202037.22%+114.8%
2019-252.00%-